Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹60,500Qualified 0 PROP OF M S GULAB MEDICOS NEAR JAGDISH HOTEL LADPURA KOTA RAJASTHAN 324005 | KOTA | RAJASTHAN | 324005 | L1 | Qualified MSE, MII, Category: General |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
1 Jan 2024, 2:00 pmClosed
PROCUREMENT OF DRUGS AND CONSUMABLES
5787058
GEM/2023/B/4383970
Two Packet Bid
ED Travoprost 0.004 percent bott of 2.5 ml,Escitalopram 10 mg tab,Fexofenadine Hydrochloride tab 12
15 days
Rajasthan; Kota
Total value wise evaluation
BOQ
7 documents required · 7 mandatory
₹31
50%
Exempted
13 Jan 2024
22 Dec 2023
1 Jan 2024
| Item No | Item Title | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|
| 1 | ED Travoprost 0.004 percent bott of 2.5 ml | 24 | No | KOTA CITY | 15 |
| 2 | Escitalopram 10 mg tab | 7,000 | No | KOTA CITY | 15 |
| 3 | Fexofenadine Hydrochloride tab 120 mg | 4,000 | No | KOTA CITY | 15 |
| 4 | Hydroxyzine HCL 25 mg tab | 3,000 | No | KOTA CITY | 15 |
| 5 | Ibandronate 150 mg tab | 30 | No | KOTA CITY | 15 |
| 6 | leflunomide 1o mg tab | 1,000 | No | KOTA CITY | 15 |
| 7 | levetiracetam 500 mg tab | 4,000 | No | KOTA CITY | 15 |
| 8 | Mefenamic Acid 250 mg and Dicyclomine HCL 10 mg tab | 1,000 | No | KOTA CITY | 15 |
| 9 | metoprolol XL 25 mg tab | 5,000 | No | KOTA CITY | 15 |
| 10 | Naproxen 250 mg tab | 2,400 | No | KOTA CITY | 15 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_5787058.pdf
GEM_BID
terms_and_conditions_2023-12-22-13-04-40_0ae4f1607854474b63e09cd3892c4770.pdf
BOQ
boq_item_sample_file_-16_2023-12-22-13-04-41_42246f2e4f31c923a7414cc0addcd6c3.csv
BOQ
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .